Corticosteroids treatment of multiple sclerosis
Köpke, S.; Heesen, C.
Journal of the neurological sciences 234(1-2): 117-8; author reply 119-20
2005
ISSN/ISBN: 0022-510X PMID: 15946686 DOI: 10.1016/j.jns.2005.01.017
Accession: 048672992
Full Text Article emailed within 0-6 h: $19.90
Related References
Myhr, K.M.; Mellgren, S.I. 2009: Corticosteroids in the treatment of multiple sclerosis Acta Neurol. Scand., Suppl 120(189): 73-80Myhr, K.M.; Mellgren, S.I. 2009: Corticosteroids in the treatment of multiple sclerosis Acta Neurologica Scandinavica. Supplementum 189: 73-80
Elovaara, I.; Pirttilä, T. 2000: Corticosteroids in the treatment of multiple sclerosis and optic neuritis Duodecim; Laaketieteellinen Aikakauskirja 116(15): 1547-1554
Ciccone, A.; Beretta, S.; Brusaferri, F.; Galea, I.; Protti, A.; Spreafico, C. 2008: Corticosteroids for the long-term treatment in multiple sclerosis Cochrane Database of Systematic Reviews 1: Cd006264
Nelson, D. 1976: Arachnoiditis From Intrathecally Given Corticosteroids in the Treatment of Multiple Sclerosis Archives of Neurology 33(5): 373-373
Ohno, R.; Hamaguchi, K.; Sowa, K.; Tanaka, H.; Watanabe, Y. 1987: High-dose intravenous corticosteroids in the treatment of multiple sclerosis Japanese Journal of Medicine 26(2): 212-216
Manova, M.; Trendafilova, L.; Hadjipetrova, E. 1995: Treatment of multiple sclerosis with cyclophosphamide and corticosteroids 2 year follow-up Journal of Neuroimmunology 1995(Suppl 1): 68
Manoya, M.; Trendafilova, L.; Hadjipetrova, E. 1995: Treatment of multiple sclerosis (Ms) with cyclophosphamide and corticosteroids: 2 year follow-up Journal of Neuroimmunology 56-63(Supp S1): 68
Dr James Goodwin 1996: High Dosage Corticosteroids in the Treatment of Optic Neuritis and Prophylaxis of Multiple Sclerosis Biodrugs 6(5): 405-412
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2012: Treatment of Exacerbations of Multiple Sclerosis without the Use of Corticosteroids The Role of Metabolic and Antioxidant Therapy Neuroscience and Behavioral Physiology 42(2): 123-127
Voltz, R.; Hohlfeld, R. 1992: Current treatment of multiple sclerosis High-dosage intravenous therapy with corticosteroids Nervenarzt 63(12): 773-775
Heun, R.; Sliwka, U.; Rüttinger, H.; Schimrigk, K. 1992: Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study Journal of Neurology 239(1): 31-35
Bisaga, G.N.; Odinak, M.M.; Boĭko, A.N.; Mel'nik, I.B.; Popova, N.F. 2011: Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(2): 44-48
Perrone, V.; Veronesi, C.; Giacomini, E.; Citraro, R.; Dell'Orco, S.; Lena, F.; Paciello, A.; Resta, A.M.; Nica, M.; Ritrovato, D.; Degli Esposti, L. 2022: The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis Clinical Epidemiology 14: 1327-1337
Henze, T.; Rieckmann, P.; Toyka, K.V. 2006: Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society European Neurology 56(2): 78-105
Tourtellotte, W.W.; Syndulko, K.; Ellison, G.; Myers, L.; Mickey, R.; Frane, M.; Kondraske, G.W. 1988: Human performance measurements hpm show that azathioprine aza combined with corticosteroids is a type of treatment of chronic progressive multiple sclerosis ms Neurology 38(3 Suppl 1): 219
Kaufman, M. 1997: Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin Multiple Sclerosis 3(4): 248-249
Yamout, B.; Alroughani, R.; Al-Jumah, M.; Goueider, R.; Dahdaleh, M.; Inshasi, J.; Hashem, S.; Alsharoqi, I.; Sahraian, M.; Khoury, S.; Alkawi, Z.; Koussa, S.; Zakaria, M.; Al Khaburi, J.; Alsaadi, T.; Bohlega, S. 2015: Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS) Current Medical Research and Opinion 31(7): 1349-1361
Heesen, C.; Solari, A.; Giordano, A.; Kasper, J.; Kopke, S. 2011: Decisions on multiple sclerosis immunotherapy: New treatment complexities urge patient engagement : A New Treatment Era in Multiple Sclerosis: Options, Challenges, Risks J. Neurol. Sci 306(1-2): 192-197
Then Bergh, F.; Kümpfel, T.; Grasser, A.; Rupprecht, R.; Holsboer, F.; Trenkwalder, C. 2001: Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial Journal of Clinical Endocrinology and Metabolism 86(4): 1610-1615